Factors affecting warfarin requirements
- 96 Downloads
In 228 ambulatory patients receiving treatment with warfarin, there was a progressive decline in the dose required to produce an equivalent degree of anticoagulant control with increasing age from the third decade onwards. However, the relationship between age and dose was significant only in patients receiving warfarin after episodes of venous thromboembolism or because of coronary artery disease. Patient weight was also related to warfarin requirements, although it was less important a determinant than age.
Key wordswarfarin anticoagulation age sex weight
Unable to display preview. Download preview PDF.
- Eccles, J.T.: Control of warfarin therapy in the elderly. Age Ageing4, 161–165 (1975)Google Scholar
- Husted, S., Andreasen, F.: Problems encountered in longterm treatment with anticoagulants. Acta Med. Scand.200, 379–384 (1976)Google Scholar
- Husted, S., Andreasen, F.: The influence of age on the response to anticoagulants. Br. J. Clin. Pharmacol.4, 559–565 (1977)Google Scholar
- O'Malley, K., Stevenson, I.H., Ward, C.A., Wood, A.J.J., Crooks, J.: Determinants of anticoagulant control in patients receiving warfarin. Br. J. Clin. Pharmacol.4, 309–314 (1977)Google Scholar
- Peyman, M.A.: The significance of haemorrhage during the treatment of patients with the coumarin anticoagulants. Acta Med. Scand. (Suppl.)339, 1–62 (1958)Google Scholar
- Shepherd, A.M.M., Hewick, D.S., Moreland, T.A., Stevenson, I.H.: Age as a determinant of sensitivity to warfarin. Brit. J. Clin. Pharmacol.4, 315–320 (1977)Google Scholar
- Toohey, M.: Clinical trial of phenylindanedione as an anticoagulant. Brit. Med. J.21, 650–652 (1953)Google Scholar